FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205177857> ?p ?o ?g. }

• W4205177857 endingPage "136" @default.
• W4205177857 startingPage "129" @default.
• W4205177857 abstract "The opioid agonist D,L-methadone exerts analgesic effects via the mu opioid receptor, encoded by OPRM1 and therefore plays a role in chronic pain management. In preclinical tumor-models D,L-methadone shows apoptotic and chemo-sensitizing effects and was therefore hyped as an off-label anticancer drug without substantiation from clinical trials. Its effects in ovarian cancer (OC) are completely unexplored.We analyzed OPRM1-mRNA expression in six cisplatin-sensitive, two cisplatin-resistant OC cell-lines, 170 OC tissue samples and 12 non-neoplastic control tissues. Pro-angiogenetic, cytotoxic and apoptotic effects of D,L-methadone were evaluated in OC cell-lines and four patient-derived tumor-spheroid models.OPRM1 was transcriptionally expressed in 69% of OC-tissues and in three of eight OC cell-lines. D,L-methadone exposure significantly reduced cell-viability in five OC cell-lines irrespective of OPRM1 expression. D,L-methadone, applied alone or combined with cisplatin, showed no significant effects on apoptosis or VEGF secretion in cell-lines. Notably, in two of the four spheroid models, treatment with D,L-methadone significantly enhanced cell growth (by up to 121%), especially after long-term exposure. This is consistent with the observed attenuation of the inhibitory effects of cisplatin in three spheroid models when adding D,L-methadone. The effect of methadone treatment on VEGF secretion in tumor-spheroids was inconclusive.Our study demonstrates that certain OC samples express OPRM1, which, however, is not a prerequisite for D,L-methadone function. As such, D,L-methadone may exert also detrimental effects by stimulating the growth of certain OC-cells and abrogating cisplatin's therapeutic effect." @default.
• W4205177857 created "2022-01-26" @default.
• W4205177857 creator A5007975306 @default.
• W4205177857 creator A5019520270 @default.
• W4205177857 creator A5024378899 @default.
• W4205177857 creator A5030148031 @default.
• W4205177857 creator A5031160235 @default.
• W4205177857 creator A5034695241 @default.
• W4205177857 creator A5037353061 @default.
• W4205177857 creator A5043341222 @default.
• W4205177857 creator A5057770862 @default.
• W4205177857 creator A5061545433 @default.
• W4205177857 creator A5061855057 @default.
• W4205177857 creator A5063354100 @default.
• W4205177857 creator A5063728196 @default.
• W4205177857 creator A5073617084 @default.
• W4205177857 creator A5076207511 @default.
• W4205177857 creator A5080638654 @default.
• W4205177857 date "2022-04-01" @default.
• W4205177857 modified "2023-10-14" @default.
• W4205177857 title "Dubious effects of methadone as an “anticancer” drug on ovarian cancer cell-lines and patient-derived tumor-spheroids" @default.
• W4205177857 cites W1778421948 @default.
• W4205177857 cites W1964677287 @default.
• W4205177857 cites W1968484007 @default.
• W4205177857 cites W1979129905 @default.
• W4205177857 cites W1983394428 @default.
• W4205177857 cites W1990588425 @default.
• W4205177857 cites W1993966541 @default.
• W4205177857 cites W1995168398 @default.
• W4205177857 cites W2001706478 @default.
• W4205177857 cites W2007206698 @default.
• W4205177857 cites W2012034410 @default.
• W4205177857 cites W2015030879 @default.
• W4205177857 cites W2020860417 @default.
• W4205177857 cites W2028398147 @default.
• W4205177857 cites W2050646488 @default.
• W4205177857 cites W2066216207 @default.
• W4205177857 cites W2069642322 @default.
• W4205177857 cites W2071319684 @default.
• W4205177857 cites W2110804787 @default.
• W4205177857 cites W2137443266 @default.
• W4205177857 cites W2142059492 @default.
• W4205177857 cites W2156511501 @default.
• W4205177857 cites W2158734599 @default.
• W4205177857 cites W2163316512 @default.
• W4205177857 cites W2230544130 @default.
• W4205177857 cites W2594589982 @default.
• W4205177857 cites W2607788676 @default.
• W4205177857 cites W2753426447 @default.
• W4205177857 cites W2792703010 @default.
• W4205177857 cites W3048469074 @default.
• W4205177857 doi "https://doi.org/10.1016/j.ygyno.2022.01.008" @default.
• W4205177857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35033381" @default.
• W4205177857 hasPublicationYear "2022" @default.
• W4205177857 type Work @default.
• W4205177857 citedByCount "2" @default.
• W4205177857 countsByYear W42051778572022 @default.
• W4205177857 crossrefType "journal-article" @default.
• W4205177857 hasAuthorship W4205177857A5007975306 @default.
• W4205177857 hasAuthorship W4205177857A5019520270 @default.
• W4205177857 hasAuthorship W4205177857A5024378899 @default.
• W4205177857 hasAuthorship W4205177857A5030148031 @default.
• W4205177857 hasAuthorship W4205177857A5031160235 @default.
• W4205177857 hasAuthorship W4205177857A5034695241 @default.
• W4205177857 hasAuthorship W4205177857A5037353061 @default.
• W4205177857 hasAuthorship W4205177857A5043341222 @default.
• W4205177857 hasAuthorship W4205177857A5057770862 @default.
• W4205177857 hasAuthorship W4205177857A5061545433 @default.
• W4205177857 hasAuthorship W4205177857A5061855057 @default.
• W4205177857 hasAuthorship W4205177857A5063354100 @default.
• W4205177857 hasAuthorship W4205177857A5063728196 @default.
• W4205177857 hasAuthorship W4205177857A5073617084 @default.
• W4205177857 hasAuthorship W4205177857A5076207511 @default.
• W4205177857 hasAuthorship W4205177857A5080638654 @default.
• W4205177857 hasBestOaLocation W42051778571 @default.
• W4205177857 hasConcept C126322002 @default.
• W4205177857 hasConcept C14397066 @default.
• W4205177857 hasConcept C154317977 @default.
• W4205177857 hasConcept C170493617 @default.
• W4205177857 hasConcept C175369904 @default.
• W4205177857 hasConcept C185592680 @default.
• W4205177857 hasConcept C190283241 @default.
• W4205177857 hasConcept C202751555 @default.
• W4205177857 hasConcept C2776694085 @default.
• W4205177857 hasConcept C2778239845 @default.
• W4205177857 hasConcept C2778767360 @default.
• W4205177857 hasConcept C2781063702 @default.
• W4205177857 hasConcept C502942594 @default.
• W4205177857 hasConcept C54355233 @default.
• W4205177857 hasConcept C55493867 @default.
• W4205177857 hasConcept C62112901 @default.
• W4205177857 hasConcept C71924100 @default.
• W4205177857 hasConcept C81885089 @default.
• W4205177857 hasConcept C86803240 @default.
• W4205177857 hasConcept C98274493 @default.
• W4205177857 hasConceptScore W4205177857C126322002 @default.
• W4205177857 hasConceptScore W4205177857C14397066 @default.
• W4205177857 hasConceptScore W4205177857C154317977 @default.

• next